--- title: "Macquarie Sticks to Their Buy Rating for WeRide Inc. Class A (0800)" type: "News" locale: "en" url: "https://longbridge.com/en/news/286627551.md" description: "Macquarie analyst maintained a Buy rating on WeRide Inc. Class A on May 14 and set a price target of HK$42.00. The company’s shares closed yesterday at HK$20.24.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks WeRide Inc. Class A has an analyst consensus of Strong Buy, with a price target consensus of HK$36.13." datetime: "2026-05-16T00:34:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286627551.md) - [en](https://longbridge.com/en/news/286627551.md) - [zh-HK](https://longbridge.com/zh-HK/news/286627551.md) --- # Macquarie Sticks to Their Buy Rating for WeRide Inc. Class A (0800) Macquarie analyst maintained a Buy rating on WeRide Inc. Class A on May 14 and set a price target of HK$42.00. The company’s shares closed yesterday at HK$20.24. ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks WeRide Inc. Class A has an analyst consensus of Strong Buy, with a price target consensus of HK$36.13. ### Related Stocks - [WRD.US](https://longbridge.com/en/quote/WRD.US.md) - [MQBKY.US](https://longbridge.com/en/quote/MQBKY.US.md) - [00800.HK](https://longbridge.com/en/quote/00800.HK.md) ## Related News & Research - [WeRide’s Global Robotaxi Expansion Meets Depressed Valuation Expectations](https://longbridge.com/en/news/286635594.md) - [WeRide Achieves Record Five Consecutive Wins at China Urban Intelligent Driving Competition | WRD Stock News](https://longbridge.com/en/news/286730764.md) - [WeRide Posts Record Q1 2026 Revenue as Global Robotaxi and ADAS Deployments Accelerate](https://longbridge.com/en/news/286250454.md) - [Maxim Group Sticks to Its Buy Rating for Newsmax Inc. Class B (NMAX)](https://longbridge.com/en/news/286573867.md) - [Haoxi Health sells 40,000,000 Class B shares to CEO for US$ 720,000 in private placement](https://longbridge.com/en/news/286961357.md)